Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease Shan Hong; Yiwei Hao; Lei Sun; Ping Li; Junru Yang; Fuyang Zhang; Lingling He; Jing Zhang; Hongshan Wei;

Relationship between sarcopenia and metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis Adnan Malik; Sadia Javaid; Muhammad Imran Malik; Shahbaz Qureshi;

Retinopathy as a predictive indicator for significant hepatic fibrosis according to T2DM status: A cross-sectional study based on the national health and nutrition examination survey data Jinze Li; Yi Xiang; Jiahao Han; Youfang Gao; Ruiying Wang; Zihe Dong; Huihui Chen; Ruixia Gao; Chuan Liu; Gao-Jun Teng; Xiaolong Qi;